Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7470860
Reference Type
Journal Article
Title
Medicinal attributes of imidazo[1,2-a]pyridine derivatives: An update
Author(s)
Devi, N; Singh, D; Rawal, RK; Bariwal, J; Singh, V
Year
2016
Is Peer Reviewed?
Yes
Journal
Current Topics in Medicinal Chemistry
ISSN:
1568-0266
Publisher
Bentham Science Publishers B.V.
Volume
16
Issue
26
Page Numbers
2963-2994
Language
English
DOI
10.2174/1568026616666160506145539
Abstract
The imidazo[1,2-a]pyridine scaffold is recognized as a privileged structure as it represents a promising area for identification of lead structures towards the discovery of new synthetic drug molecules. Several commercial drugs such as Zolpidem, Olprinone, Soraprazan and many other compounds in biological testing and preclinical evaluation, illustrate the wide therapeutic spectrum in this class of drug scaffolds. The present manuscript represents the assimilation of literature pertaining to medicinal aspects of this pharmacophore including the structure-activity relationships. © 2016 Bentham Science Publishers.
Keywords
Groebke-Blackburn-Bienayme reaction; Imidazo[1,2-a]pyridine; Multicomponent reaction; N-fused imidazole; SAR; Ugi type; 2 (5 substituted) 1,3,4 oxadiazole 2 yl) h imidazo[1,2 a]pyridine derivative; 2 amino 3 substituted 6 [(e) 1 phenyl 2 (N methyl carbamoyl)vinyl] imidazo[1,2 a] pyridine derivative; 2 aryl 3 [2 aminopyrimidin 4 yl] imidazopyridine derivative; 2 [(4 phenylpiperazin 1 yl)methyl] imidazoazine pyridine derivative; 3 (1 [(4 fluorophenyl)sulfonyl] 1h pyrazol 3 yl) 2 methylimidazo [1,2 a] pyridine derivative; 6 substituted 2 (h trifluoroacetylamino)imidazo pyridine derivative; 6 substituted methyl imidazo[1,2 a]pyridine 2 carbamate derivative; antileishmanial agent; bromodomain inhibitor; coccidiostatic agent; cyclin dependent kinase; DNA topoisomerase (ATP hydrolysing); growth factor receptor; imidazo [1,2 a] pyridine derivative; imidazo[1,2 a]pyridin 3 amine derivative; imidazo[1,2 a]pyridine 8 carboxamide derivative; imidazo[1,2 a]pyridine amide derivative; imidazo[1,2 a]pyridine derivative; interleukin 1 receptor associated kinase 4; kinesin; n,n dialkyl 2 phenylimidazo[1,2 a]pyridine 3 acetamide derivative; n,n dialkyl 2 phenylimidazo[1,2 a]pyridine 3 propionamide derivative; nicotinamide phosphoribosyltransferase; peptides and proteins; phosphatidylinositol 3 kinase; soraprazan; unclassified drug; unindexed drug; vasculotropin receptor 2; zolpidem; [6 iodo 2 (4 n,n dimethylamino) phenylimidazo[1,2 a]pyridine] derivative; antiinfective agent; DNA; imidazole derivative; pyridine derivative; Alzheimer disease; anthelmintic activity; antibacterial activity; anticonvulsant activity; antidiabetic activity; antifungal activity; antiinflammatory activity; antimalarial activity; antineoplastic activity; antiproliferative activity; antiulcer activity; antiviral activity; Article; clinical trial (topic); drug activity; drug screening; human; insecticidal activity; nonhuman; nucleoside transport; oxidative coupling; structure activity relation; chemistry; drug effects; Anti-Infective Agents; DNA; Imidazoles; Pyridines; Structure-Activity Relationship
Tags
Other
•
Harmful Algal Blooms- Health Effects
April 2021 Literature Search
Scopus
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity